UNSPSC 51142503: Levodopa

This classification denotes a dopamine agonist with the molecular formula C9H11NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 46627O600J, chemically known as 3,4-dihydroxyphenyl-l-alanine but generally known as levodopa, which bears US NIH Compound Identifier 836. European Medicines Agency schedules Levodopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08468MIG.

UNSPSC 51142503 Levodopa is a Commodity code that shows little relevant recent activity under state and local procurement. The three opportunities tagged to this code in recent postings do not involve the pharmaceutical product named in the code. Washington County, Oregon posted an RFP for a District Attorney's Office Dog (due August 14, 2026), the City of Tucson solicited athletic training services for fire and police departments (RFP, due June 9, 2026), and the City of Tampa's Fire Rescue Department issued an ITB for medical aid supplies including bandages, antiseptic sprays, and first aid kits (due April 9, 2025). None of these opportunities align with procurement of levodopa or neurological pharmaceuticals.

The mislabeling of these opportunities under the levodopa code suggests either a data-entry error in the tagging system or a systematic misclassification. State and local agencies do purchase pharmaceuticals through formulary contracts and emergency medical supply agreements, but the recent opportunities visible under this code reflect general first aid and occupational health services rather than prescription medication. Business development professionals should verify whether state and local procurement activity in levodopa actually exists through direct outreach to pharmacy benefit managers, health department contacts, and correctional health service providers, rather than relying on this code's recent posting record.